Free Trial

QT Imaging (QTI) Competitors

QT Imaging logo
$2.10 +0.02 (+0.96%)
As of 07/9/2025

QTI vs. PDEX, RCEL, AVR, INFU, LAKE, PTHL, LUCD, LUNG, OBIO, and ICAD

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include Pro-Dex (PDEX), Avita Medical (RCEL), Anteris Technologies Global (AVR), InfuSystem (INFU), Lakeland Industries (LAKE), Pheton (PTHL), Lucid Diagnostics (LUCD), Pulmonx (LUNG), Orchestra BioMed (OBIO), and icad (ICAD). These companies are all part of the "medical equipment" industry.

QT Imaging vs. Its Competitors

QT Imaging (NASDAQ:QTI) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 47.5% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

QT Imaging has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500.

Pro-Dex has a consensus target price of $56.00, indicating a potential upside of 17.25%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Pro-Dex has a net margin of 14.61% compared to QT Imaging's net margin of 0.00%. Pro-Dex's return on equity of 29.08% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
Pro-Dex 14.61%29.08%16.19%

In the previous week, QT Imaging had 1 more articles in the media than Pro-Dex. MarketBeat recorded 2 mentions for QT Imaging and 1 mentions for Pro-Dex. QT Imaging's average media sentiment score of 0.38 beat Pro-Dex's score of 0.00 indicating that QT Imaging is being referred to more favorably in the media.

Company Overall Sentiment
QT Imaging Neutral
Pro-Dex Neutral

Pro-Dex has higher revenue and earnings than QT Imaging.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$4.00M14.26-$4.03MN/AN/A
Pro-Dex$53.84M2.89$2.13M$2.8017.06

Summary

Pro-Dex beats QT Imaging on 9 of the 14 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$56.98M$34.11M$5.57B$9.02B
Dividend YieldN/AN/A5.25%4.03%
P/E RatioN/A3.3927.1820.14
Price / Sales14.26195.25417.49184.08
Price / CashN/A41.3637.0657.97
Price / Book-1.102.148.085.60
Net Income-$4.03M-$25.54M$3.16B$248.50M
7 Day Performance45.83%7.53%3.77%5.15%
1 Month Performance165.82%165.88%3.90%7.62%
1 Year Performance194.78%136.57%34.22%21.56%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
N/A$2.10
+1.0%
N/A+181.1%$56.98M$4.00M0.00N/A
PDEX
Pro-Dex
1.7994 of 5 stars
$43.59
-0.1%
$56.00
+28.5%
+177.7%$142.10M$53.84M15.57140
RCEL
Avita Medical
0.8713 of 5 stars
$5.27
-0.4%
$16.50
+213.1%
-33.7%$139.31M$71.66M-2.41130High Trading Volume
AVR
Anteris Technologies Global
N/A$3.72
-1.8%
$16.50
+343.5%
N/A$134.14M$2.70M0.00138Positive News
INFU
InfuSystem
1.9355 of 5 stars
$6.18
-1.0%
$13.00
+110.4%
N/A$129.88M$137.58M103.02410News Coverage
LAKE
Lakeland Industries
4.721 of 5 stars
$13.62
+0.1%
$26.00
+90.9%
-35.5%$129.53M$167.21M-4.522,100Positive News
High Trading Volume
PTHL
Pheton
N/A$18.33
-0.3%
N/AN/A$120.61M$450K0.0011High Trading Volume
LUCD
Lucid Diagnostics
2.2 of 5 stars
$1.10
-4.3%
$3.55
+222.7%
+33.5%$119.01M$4.35M-0.8270Positive News
High Trading Volume
LUNG
Pulmonx
3.1606 of 5 stars
$2.69
+3.9%
$11.53
+328.4%
-57.3%$108.30M$83.79M-1.87250News Coverage
OBIO
Orchestra BioMed
2.6547 of 5 stars
$2.77
+3.4%
$14.20
+412.6%
-62.8%$106.12M$2.64M-1.564News Coverage
ICAD
icad
0.7912 of 5 stars
$3.72
-2.4%
N/A+208.7%$102.19M$19.61M-19.58140News Coverage

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners